Influence of Lipoxygenase Inhibition on Glioblastoma Cell Biology.

Int J Mol Sci

Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 03001-000, Brazil.

Published: November 2020

Background: The relationship between glioblastoma (GBM) and fatty acid metabolism could be the key to elucidate more effective therapeutic targets. 15-lipoxygenase-1 (15-LOX), a linolenic acid and arachidonic acid metabolizing enzyme, induces both pro- and antitumorigenic effects in different cancer types. Its role in glioma activity has not yet been clearly described. The objective of this study was to identify the influence of 15-LOX and its metabolites on glioblastoma cell activity.

Methods: GBM cell lines were examined using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) to identify 15-LOX metabolites. GBM cells treated with 15-LOX metabolites, 13-hydroxyoctadecadeinoic acid (HODE) and 9-HODE, and two 15-LOX inhibitors (luteolin and nordihydroguaiaretic acid) were also examined. Dose response/viability curves, RT-PCRs, flow cytometry, migration assays, and zymograms were performed to analyze GBM growth, migration, and invasion.

Results: Higher quantities of 13-HODE were observed in five GBM cell lines compared to other lipids analyzed. Both 13-HODE and 9-HODE increased cell count in U87MG. 15-LOX inhibition decreased migration and increased cell cycle arrest in the G2/M phase.

Conclusion: 15-LOX and its linoleic acid (LA)-derived metabolites exercise a protumorigenic influence on GBM cells in vitro. Elevated endogenous levels of 13-HODE called attention to the relationship between linoleic acid metabolism and GBM cell activity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664864PMC
http://dx.doi.org/10.3390/ijms21218395DOI Listing

Publication Analysis

Top Keywords

15-lox metabolites
12
gbm cell
12
glioblastoma cell
8
acid metabolism
8
cell lines
8
gbm cells
8
increased cell
8
linoleic acid
8
cell
7
gbm
7

Similar Publications

12/15-Lipoxygenase-Derived Electrophilic Lipid Modifications in Phagocytic Macrophages.

ACS Chem Biol

January 2025

Division of Physiological Chemistry and Metabolism, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-0011, Japan.

Macrophages remove apoptotic cells via phagocytosis, also known as efferocytosis, during inflammation to maintain tissue homeostasis. This process is accompanied by various metabolic changes in macrophages including the production of lipid metabolites by fatty acid oxygenases. Among these, highly reactive metabolites, called lipid-derived electrophiles (LDEs), modify cysteines and other nucleophilic amino acids in intracellular proteins.

View Article and Find Full Text PDF

Background: Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease (NSAIDs-ERD) is characterized by altered arachidonic acid (AA) metabolism. Aspirin hypersensitivity is diagnosed using aspirin challenge, while induced sputum is collected to perform cell counts and to identify local biomarkers in induced sputum supernatant (ISS). This study aimed to assess the levels of a newly identified eicosanoid, 15-oxo-eicosatetraenoic acid (15-oxo-ETE), in ISS at baseline and during aspirin-induced bronchospasm in patients with NSAIDs-ERD.

View Article and Find Full Text PDF

The neo-potential therapeutic strategy in preeclampsia: Downregulated miR-26a-2-3p motivates endothelial cell injury by targeting 15-LOX-1.

Free Radic Biol Med

November 2024

Department of Pharmacy, Women and Children's Hospital of Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing Medical University, Chongqing, China. Electronic address:

Article Synopsis
  • * In experiments, reduced 15-LOX-1 expression led to decreased endothelial injury in a mouse model, while hypoxia was shown to promote negative effects on endothelial cells through the activation of the p38 MAPK pathway.
  • * The study also identified a regulatory connection between 15-LOX-1 and miR-26a-2-3p, suggesting that targeting this
View Article and Find Full Text PDF
Article Synopsis
  • Impaired blood flow in the brain due to blood vessel constriction and microthrombi can lead to delayed cerebral ischemia following a subarachnoid hemorrhage (SAH).
  • The overexpression of 12/15-Lipooxygenase (12/15-LOX) is linked to poor early brain injury outcomes, and the study investigates its role in delayed effects after SAH.
  • Results show that inhibiting 12/15-LOX improves brain perfusion and reduces negative outcomes like microvessel constriction and platelet activation, suggesting it could be a key target for treatment after SAH.
View Article and Find Full Text PDF

Background And Purpose: Impaired cerebral circulation, induced by blood vessel constrictions and microthrombi, leads to delayed cerebral ischemia after subarachnoid hemorrhage (SAH). 12/15-Lipooxygenase (12/15-LOX) overexpression has been implicated in worsening early brain injury outcomes following SAH. However, it is unknown if 12/15-LOX is important in delayed pathophysiological events after SAH.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!